Bowhead Specialty director acquires 4,038 company shares at no cost

Bowhead Specialty Holdings Inc. director reported acquiring additional common stock in the company.

Rhea-AI Filing Summary

Bowhead Specialty Holdings Inc. director reported acquiring additional common stock in the company. On May 1, 2025, the reporting person acquired 4,038 shares of common stock at a stated price of $0, bringing their directly held beneficial ownership to 36,773 shares after the transaction.

The footnotes explain that this total includes 23,324 shares of common stock that were previously received on September 19, 2024 for no consideration, as part of a pro rata distribution connected to the dissolution of Bowhead Insurance Holdings LP. That earlier acquisition was treated as exempt from reporting under Rule 16a-9 of the Securities Exchange Act of 1934.

Insider Trade Summary

Grant/Award: 4,038 shares

Grant/Award 1 txn

Insider Brock-Kyle Angela

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,038	$0.00	$0.00

Holdings After Transaction: Common Stock — 36,773 shares (Direct)

Footnotes (1)

1. F1. Includes 23,324 shares of common stock received on September 19, 2024, for no consideration, as part of a pro rata distribution in connection with the dissolution of Bowhead Insurance Holdings LP. Such acquisition was exempt from reporting pursuant to Rule 16a-9 of the Securities Exchange Act of 1934.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bowhead Specialty Holdings Inc. (BOW) report on this Form 4/A?

The filing reports that a director of Bowhead Specialty Holdings Inc. acquired 4,038 shares of common stock on May 1, 2025 at a stated price of $0.

How many Bowhead Specialty Holdings Inc. (BOW) shares does the reporting person own after the transaction?

Following the reported transaction, the reporting person beneficially owns 36,773 shares of Bowhead Specialty Holdings Inc. common stock, held directly.

What is the significance of the 23,324 Bowhead Specialty (BOW) shares mentioned in the footnote?

The 23,324 shares were received on September 19, 2024 for no consideration as part of a pro rata distribution related to the dissolution of Bowhead Insurance Holdings LP, and that acquisition was exempt from reporting under Rule 16a-9.

What is the relationship of the reporting person to Bowhead Specialty Holdings Inc. (BOW)?

The reporting person is identified as a director of Bowhead Specialty Holdings Inc. and is filing as a single reporting person.

Does this Bowhead Specialty Holdings Inc. (BOW) Form 4/A involve any derivative securities?

The presented Table II for derivative securities does not list any specific derivative transactions or holdings, indicating that only non-derivative common stock is reported in this excerpt.

Was the Bowhead Specialty (BOW) insider transaction made under a Rule 10b5-1 trading plan?

The form includes a checkbox for transactions made under a Rule 10b5-1(c) trading plan, but the excerpt does not indicate that this box was checked for the reported acquisition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/06/2026 - 04:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brock-Kyle Angela

(Last) (First) (Middle)

C/O BOWHEAD SPECIALTY HOLDINGS INC.

452 FIFTH AVENUE

(Street)

NEW YORK NY 10018

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bowhead Specialty Holdings Inc. [ BOW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/02/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/01/2025		A		4,038(1)	A	$0	36,773	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 23,324 shares of common stock received on September 19, 2024, for no consideration, as part of a pro rata distribution in connection with the dissolution of Bowhead Insurance Holdings LP. Such acquisition was exempt from reporting pursuant to Rule 16a-9 of the Securities Exchange Act of 1934.

Remarks:

	/s/ H. Matthew Crusey, as attorney-in-fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.